NCT06882564 is a Phase 3 clinical trial of resveratrol mouthwash in Halitosis, sponsored by Al-Mustansiriyah University.

Who is sponsoring NCT06882564?

NCT06882564 is sponsored by Al-Mustansiriyah University.

What drugs are being tested in NCT06882564?

Interventions in NCT06882564: resveratrol mouthwash, Chlorhexidine mouthwash (0.2%), Placebo.

What condition does NCT06882564 study?

NCT06882564 studies Halitosis, Mouth Disease, Plaque Induced Gingival Disease, Bleeding Gum, Peridontal Disease.

Is NCT06882564 still recruiting?

NCT06882564 is currently recruiting now. Last updated 18 March 2025.

Last reviewed 2025-03-18 · How we verify

NCT06882564

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

Recruiting now Phase 3 Last updated 18 March 2025

What this trial tests

Phase 3 trial testing resveratrol mouthwash in Halitosis in 54 participants. Currently enrolling.

Timeline

5 January 2025

Primary endpoint
1 April 2025

1 November 2025

Quick facts

Lead sponsor	Al-Mustansiriyah University
Phase	Phase 3
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	54
Start date	5 January 2025
Primary completion	1 April 2025
Estimated completion	1 November 2025
Sites	1 location across Iraq

Drugs / interventions tested

resveratrol mouthwash — full drug profile →
Chlorhexidine mouthwash (0.2%) — full drug profile →
Placebo

Conditions studied

Halitosis — all drugs for Halitosis →
Mouth Disease — all drugs for Mouth Disease →
Plaque Induced Gingival Disease — all drugs for Plaque Induced Gingival Disease →
Bleeding Gum — all drugs for Bleeding Gum →

Sponsor

Al-Mustansiriyah University

Who can join

Adults 20 to 24, any sex, with Halitosis or Mouth Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study: To assess the efficacy of antioxidant (resveratrol) mouthwash in reducing the level of p. gingivitis and oral malodor over 7 day period among undergraduate dental student patients from Mustansiriyah University/College of Dentistry and Wasit University /College of Dentistry. Objectives: * To assess the efficacy of anti-oxidant and anti-inflammatory resveratrol mouthwash in reducing halitosis in undergraduate students with plaque-induced gingivitis patients. * To assess the efficacy of resveratrol mouthwash in reducing p. gingivalis in undergraduate students' patients with oral malodor. * To determine the relation between p.gingivalis and clinical periodontal parameters (plaque index, gingival index, bleeding on probing) among undergraduate students with plaque-induced gingivitis and halitosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of a Mouthwash Containing Resveratrol in Reducing Halitosis-related P. gingivalis: A Randomized Triple-blind Trial.
Abed Taher NA, Mahmood AA, Hussein HM. · · 2025 · PMID 41328922 · DOI 10.3290/j.ohpd.c_2373

Verify or expand the search:

Other recruiting trials for Halitosis

Currently open trials in the same condition.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT06900881 — Role of Kefir Mouth Wash in Oral Health Status Amelioration · Phase 2, PHASE3 · recruiting
NCT06583720 — Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis · Phase 1 · recruiting
NCT06483646 — Evaluation of the Stability of Sulfur Volatile Compounds From Exhaled Air for Halitosis Diagnosis · NA · recruiting
NCT06091228 — The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy · NA · recruiting

Other Al-Mustansiriyah University trials

Trials by the same sponsor.

NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
NCT06921434 — the Effect of Monk Fruit and Splenda on Salivary Ph and Streptococcus Mutans Count in Vivo Study · NA · not yet recruiting
NCT07182526 — Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycys · Phase 2 · recruiting
NCT07493291 — Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients · active not recruiting
NCT07020078 — Oral Health Condition Among a Group of Ionizing Radiation Field Workers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06882564 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Mustansiriyah University
Last refreshed: 18 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06882564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing